drugset / Trial / NCT05646719
Safety and Efficacy of Nyxol Eye Drops as a Single Agent and With Adjunctive Low-Dose Pilocarpine Eye Drops in Subjects With Presbyopia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objectives of this study are: To evaluate the safety and efficacy of Nyxol alone and with adjunctive low dose pilocarpine to improve distance-corrected near visual acuity (DCNVA) in subjects with presbyopia.
Timeline
- Start
- 2022-12-22
- Primary completion
- 2023-10-11
- Completion
- 2023-10-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Phentolamine | Small molecule | 0.75 % | Other |
| Subject | Pilocarpine | Unknown | 0.4 % | Other |